Effects of intragastric balloon versus conservative therapy on appetite regulatory hormones in obese subjects

Trends in Medical Research

Volumn 9, Issue 2, 2014, Pages 58-80

  Mohammed, Mohammed Amin ^a   Anwar, Rokia ^a   Mansour, Amany H ^a   Elmasry, Emad ^a   Othman, Gamal ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Adiponectin; Ghrelin; Insulin; Leptin; Obesity

Indexed keywords

ADIPONECTIN; GHRELIN; INSULIN; LEPTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIET; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE; FEMALE; GASTRIC BALLOON; GASTROSCOPE; GASTROSCOPY; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION;

EID: 84899632550     PISSN: 18193587     EISSN: 21516065     Source Type: Journal    
DOI: 10.3923/tmr.2014.58.80     Document Type: Article

References (57)

1. Anderson, M.A., S.I. Gan, R.D. Fanelli, T.H. Baron and S. Banerjee et al., 2008. Role of endoscopy in the bariatric surgery patient. Gastrointest. Endosc, 68: 1-10.
2. Babinska, Z., P. Bandosz, T. Zdrojewski and B. Wyrzykowski, 2004. Epidemiologia otylosci i otylosci brzusznej w Polsce, Europie Zachodniej i USA [The epidemiology of obesity and abdominal obesity in Poland, Western Europe and the US]. Kardiologia w Praktyce, 5: 3-7.
3. Bacha, F., R. Saad, N. Gungor and S.A. Arslanian, 2004. Adiponectin in youth: Relationship to visceral adiposity, insulin sensitivity and P-cell function. Diabetes Care, 27: 547-552.
4. Bleich, S., D. Cutler, C. Murray and A. Adams, 2008. Why is the developed world obese? Annu. Rev. Public Health J, 29: 273-295.
5. Cannon, W.B. and A.L. Washburn, 1993. An explanation of hunger. Obes. Res., 1: 494-500.
6. Chernik, DA., D. Gillings, H. Laine, J. Hendler and J.M. Silver et al., 1990. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. J. Clin. Psychopharmacol., 10: 244-251.
7. Ciccone, M.M., V. Miniello, R. Marchioli, P. Scicchitano and F. Cortese et al., 2011. Morphological and functional vascular changes induced by childhood obesity. Eur. J. Cardiovasc. Prev. Rehabil, 18: 831-835.
8. Colquitt, J.L., J. Picot, E. Loveman and A.J. Clegg, 2009. Surgery for obesity. Cochrane Datab. Syst. Rev,. 10.1002/14651858.CD003641.pub3
9. Cote, G.A. and S.A. Edmundowicz, 2009. Emerging technology: Endoluminal treatment of obesity. Gastromtest. Endosc, 70: 991-999.
10. Cummmgs, D.E, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellmger and J.Q. Purnell, 2002. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med, 346: 1623-1630.
11. Deurenberg, P, J.A. Weststrate and J.C. Seidell, 1991. Body mass index as a measure of body fatness: Age- and sex-specific prediction Br. J. Nutr, 65: 105-114.
12. DiBaise, J.K, H. Zhang, M.D. Crowell, R. Krajmalnik-Brown, G.A. Decker and B.E. Rittmann, 2008. Gut microbiota and its possible relationship with obesity. Mayo. Clin. Proc, 83: 460-469.
13. Dixon, J.B, P.E. O'Brien, J. Playfair, L. Chapman and L.M. Schachter et al., 2008. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. J. Am. Med. Assoc, 23: 316-323.
14. Doldi, S.B, G. Micheletto, M.N. Perrmi, M.C. Librenti and S. Rella, 2002. Treatment of morbid obesity with intragastric balloon in association with diet. Obes. Surg, 12: 583-587.
15. Dumonceau, J.M, 2008. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg, 18: 1611-1617.
16. El-Serag, H.B, 2005. Obesity and disease of the esophagus and colon. Gastroenterol. Clin. North Am, 34: 63-82.
17. Ello-Martin, J.A, J.H. Ledikwe and B.J. Rolls, 2005. The influence of food portion size and energy density on energy intake: Implications for weight management. Am. J. Clin. Nutr, 82: 236S-241S.
18. Evans, J.D. and M.H. Scott, 2001. Intragastric balloon in the treatment of patients with morbid obesity. Br. J. Surg, 88: 1245-1248.
19. Evans, J.T. and M.H. DeLegge, 2011. Intragastric balloon therapy in the management of obesity. Why the bad wrap? J. Parenter Enteral. Nutr, 35: 25-31.
20. Faraj, M, P.J. Havel, S. Phehs, D. Blank, A.D. Smderman and K. CianfLone, 2003. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab, 88: 1594-1602.
21. Fauci, A, E. Braunwald, D. Kasper, S. Hauser, D. Longo, J. Jameson and J. Loscalzo, 2008. Harrisons Principles of Internal Medicine. 17th Edn, McGraw-Hill Inc., New York, ISBN-10: 0071466339, Pages: 2958.
22. Flier, J.S., 2004. Obesity wars: Molecular progress confronts an expanding epidemic. Cell, 116:337-350.
23. Flint, A., A. Raben, J.E. Blundell and A. Astrup, 2000. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord., 24: 38-48.
24. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem, 18: 499-502.
25. Galloro, G., G.D. de Raima, C. Catanzano, M. de Luca and C. de Werra et al., 1999. Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity. Obes. Surg., 9: 68-71.
26. Ganesh, R., A.D. Rao, H.G. Baladas and T. Leese, 2007. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: Poor results in Asian patients. Singapore Med. J., 48: 227-231.
27. Geliebter, A., 1988. Gastric distension and gastric capacity in relation to food intake in humans. Physiol. Behav, 44: 665-668.
28. Genco, A., M. Cipriano, V. Bacci, M. Cuzzolaro and A. Materia et al., 2006. BioEnterics® Intragastric Balloon (BIB®): A short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int. J. Obes., 30: 129-133.
29. Green, D.J., 2009. Is body mass index really the best measure of obesity in individuals? J. Am. Coll. Cardiol, 53: 526-526.
30. Haslam, D.W. and W.P. James, 2005. Obesity. Lancet, 366: 1197-1209.
31. Herve, J, C.H. Wahlen, A. Schaeken, B. Dallemagne and J.M. Dewandre et al, 2005. What becomes of patients one year after the intragastric balloon has been removed? Obes. Surg, 15: 864-870.
32. Imaz, I, C. Martinez-Cervell, E.E. Garcia-Alvarez, J.M. Sendra-Gutierrez and J. Gonzalez-Enriquez, 2008. Safety and effectiveness of the intragastric balloon for obesity. A metaanalysis. Obes. Surg, 18: 841-846.
33. Kalra, S.P, N. Ueno and P.S. Kalra, 2005. Stimulation of appetite by ghrelin is regulated by leptin restraint: Peripheral and central sites of action. J. Nutr, 135: 1331-1335.
34. Katz, A, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, G. Sullivan and M.J. Quon, 2000. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab, 85: 2402-2410.
35. Kim, H.B, E.S. Lee, S.W. Oh, Y.H. Kim and D.E. Lee et al., 2008. Validity, reproducibility of visual analogue scales in assessment of appetite sensations. J. Korean Acad. Fam. Med, 29: 736-745.
36. Kindt, S. and J. Tack, 2006. Impaired gastric accommodation and its role in dyspepsia. Gut, 55: 1685-1691.
37. Konopko-Zubrzycka, M, A. Baniukiewicz, E. Wroblewski, I. Kowalska, W. Zarzycki, M. Gorska and A. Dabrowski, 2009. The effect of intragastric balloon on plasma ghrelin, leptin and adiponectin levels in patients with morbid obesity. J. Clin. Endocrinol. Metab, 94: 1644-1649.
38. Leidy, H.J, J.K. Gardner, B.R. Frye, M.L. Snook, M.K. Schuchert, E.L. Richard and N.I. Williams, 2004. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J. Clin. Endocrinol. Metab, 89: 2659-2664.
39. Martinez-Brocca, M.A, O. Belda, J. Parejo, L. Jimenez and A. del Valle et al., 2007. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes. Surg, 17: 649-657.
40. Matthews, D.R, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner, 1985. Homeostasis model assessment: Insulin resistance and P-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419.
41. Mion, F., R. Gincul, S. Roman, S. Beorchia and F. Hedelius et al., 2007. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: Results of a prospective multicenter study. Obes. Surg, 17: 764-769.
42. Mokdad, A.H, J.S. Marks, D.F. Stroup and J.L. Gerberding, 2004. Actual causes of death in the United States, 2000. J. Am. Med. Assoc, 291: 1238-1245.
43. Nakazato, M, N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa and S. Matsukura, 2001. A role for ghrelin in the central regulation of feeding. Nature, 409: 194-198.
44. Ogden, C.L, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak and KM. Flegal, 2006. Prevalence of overweight and obesity in the United States, 1999-2004. J. Am. Med. Assoc, 295: 1549-1555.
45. Ryan, A.S, D.M. Berman, B.J. Nicklas, M. Smha and R.L. Gmgench et al., 2003. Plasma adiponectin and leptin levels, body composition and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care, 26: 2383-2388.
46. Sallet, J.A, J.B. Marchesini, D.S. Paiva, K. Komoto and C.E. Pizani et al., 2004. Brazilian multicenter study of the intragastric balloon. Obes. Surg, 14: 991-998.
47. Schapiro, M, S. Benjamin, G. Blackburn, B. Frank and D. Heber et al., 1987. Obesity and the gastric balloon: A comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. Gastrointest. Endosc, 33: 323-327.
48. Strychar, I, 2006. Diet in the management of weight loss. Can. Med. Assoc. J, 174: 56-63.
49. Swidnicka-Siergiejko, A, E. Wroblewski and D. Andrzej, 2011. Endoscopic treatment of obesity. Can. J. Gastroenterol, 25: 627-633.
50. Tschop, M, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin and M.L. Heiman, 2001. Circulating ghrelin levels are decreased in human obesity. Diabetes, 50: 707-709.
51. WHO, 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
52. WHO, 2003. Obesity and Overweight. World Health Organization, Geneva, USA.
53. WMA, 2013. Declaration of Helsinki: Ethical principles for medical research involving human subjects. 18th WMA General Assembly, Helsinki, Finland, June 1964 and Amended by the 64th WMA General Assembly, World Medical Association, Fortaleza, Brazil, October, 2013.
54. Weigle, D.S, D.E. Cummmgs, P.D. Newby, P.A. Breen and R.S. Frayo et al., 2003. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J. Clin. Endocrinol. Metab, 88: 1577-1586.
55. Wickremesekera, K, G. Miller, T.D. Naotunne, G. Knowles and R.S. Stubbs, 2005. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: A time course study. Obes. Surg, 15:474-481.
56. Williams, D.L, D.E. Cummmgs, H.J. Grill and J.M. Kaplan, 2003. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology, 144: 2765-2767.
57. Williams, D.L. and D.E. Cummings, 2005. Regulation of ghrelin in physiologic and pathophysiologic states. J. Nutr, 135: 1320-1325.